GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (NAS:CVAC) » Definitions » Other Current Payables

CVAC (CureVac NV) Other Current Payables : $0.0 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is CureVac NV Other Current Payables?

CureVac NV's Other Current Payables for the quarter that ended in Dec. 2024 was $0.0 Mil.

CureVac NV's quarterly Other Current Payables declined from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil) but then stayed the same from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).


CureVac NV Other Current Payables Historical Data

The historical data trend for CureVac NV's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CureVac NV Other Current Payables Chart

CureVac NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Payables
Get a 7-Day Free Trial 0.65 0.04 - - -

CureVac NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CureVac NV Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


CureVac NV Other Current Payables Related Terms

Thank you for viewing the detailed overview of CureVac NV's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


CureVac NV Business Description

Address
Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.